Disease-Modifying Therapies in Frontotemporal Lobar Degeneration
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
1008-1020
Author(s):
B. Bigni, E. Premi, A. Pilotto, A. Padovani and B. Borroni
Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
1131-1147
Author(s):
Masashi Kitazawa, Rodrigo Medeiros and Frank M. LaFerla
Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses
Journal:
Current Bioinformatics
Volume:
7
Page:
87-95
Author(s):
Anita Sarkar, Sonu Kumar, Abhinav Grover and Durai Sundar
PP2A and Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
9
Page:
248-256
Author(s):
L. Torrent and I. Ferrer
Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics
Journal:
Current Neuropharmacology
Volume:
9
Page:
623-631
Author(s):
Jose F. Abisambra, Umesh K. Jinwal, Jeffrey R. Jones, Laura J. Blair, John Koren III and Chad A. Dickey
Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Journal:
Current Alzheimer Research
Volume:
8
Page:
893-901
Author(s):
Lars Frings, Stefan Kloppel, Stefan Teipel, Oliver Peters, Lutz Frolich, Johannes Pantel, Johannes Schroder, Hermann-Josef Gertz, Sonke Arlt, Isabella Heuser, Johannes Kornhuber, Jens Wiltfang, Wolfgang Maier, Frank Jessen, Harald Hampel and Michael Hull
Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
10
Page:
928-935
Author(s):
Abdulaziz A. Al-Jafari, Shazi Shakil, Marcella Reale and Mohammad A. Kamal
Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3356-3373
Author(s):
Russell H. Swerdlow
Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3398-3412
Author(s):
Natacha Coppieters and Mike Dragunow
Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3413-3417
Author(s):
Illana Gozes